ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
TissueTech Receives FDA Clearance for TTAX03 Study to Treat Facet Joint Osteoarthritis Pain
March 12, 2021Amniox Medical announced its parent company TissueTech had received clearance from the U.S. Food and Drug Administration (FDA) to proceed with a dosing study using its Investigational New Drug (IND) TTAX03 to treat facet joint pain resulting from OA.
Pharma Sources Insight January 2025
